Five Years into the Product Patient Regime: India's Response

Document Summary

Many developing countries are able to access affordable medicines as a result of utilizing flexibilities in the WTO TRIPS Agreement. Hence, developments in India have impacts well beyond its borders, given the reliance of the global market, especially developing and least developed countries (LDCs), on the supply of low-cost, quality Indian generic pharmaceutical products.